ZFYVE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.09649955781776E-10 |
Normal-vs-Stage2 |
4.95530000366173E-08 |
Normal-vs-Stage3 |
1.62436730732907E-12 |
Normal-vs-Stage4 |
1.66533453693773E-15 |
Stage1-vs-Stage2 |
1.596150E-02 |
Stage1-vs-Stage3 |
2.79280000015092E-07 |
Stage1-vs-Stage4 |
1.6985399999947E-05 |
Stage2-vs-Stage3 |
5.051400E-01 |
Stage2-vs-Stage4 |
3.153400E-01 |
Stage3-vs-Stage4 |
5.763200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
8.58279999960132E-07 |
Normal-vs-Asian |
7.996100E-03 |
Caucasian-vs-AfricanAmerican |
4.230000E-01 |
Caucasian-vs-Asian |
4.894200E-01 |
AfricanAmerican-vs-Asian |
7.180200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62436730732907E-12 |
Normal-vs-Female |
3.21964677141295E-15 |
Male-vs-Female |
4.288400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.574800E-04 |
Normal-vs-Age(41-60Yrs) |
1.14509957072073E-10 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
3.02710079225221E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.312600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.618000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.088800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997580E-04 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.006310E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.896200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.662000E-01 |
Normal-vs-Grade 2 |
9.12603326241879E-14 |
Normal-vs-Grade 3 |
1.11022302462516E-16 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
1.844880E-03 |
Grade 1-vs-Grade 3 |
5.849100E-04 |
Grade 1-vs-Grade 4 |
1.48519999998431E-06 |
Grade 2-vs-Grade 3 |
3.112500E-02 |
Grade 2-vs-Grade 4 |
2.30139999999324E-05 |
Grade 3-vs-Grade 4 |
2.075700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.65445435129641E-12 |
Normal-vs-ccB subtype |
1.10034203970599E-12 |
ccA subtype-vs-ccB subtype |
3.448000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62825308791525E-12 |
Normal-vs-N1 |
1.63447033685316E-12 |
N0-vs-N1 |
1.821870E-04 |
|
|